Sign in
Active, not recruitingNo phase

Zenith Thoracic Alpha (ZTA) Post-Market Data Collection

Key facts

Who runs it
Cook Research Incorporated
Where
France, Germany, Italy, and Netherlands10 sites in 4 countriesChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
300 people, planned
Started
6 Jul 2023
Expected to end
1 Dec 2034
Type of study
Observational
Treatments tested
  • Endovascular aortic treatment
Record updated
27 February 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Patient has been treated/was intended to be treated with ZTA according to the clinical practice from Jan 2019 until site initiation
  • The patient is willing to participate in the study and provide written informed consent for study participation or express non-objection or give written consent per local requirements prior to data collection of any data from medical records

Who cannot take part

  • A patient treated with a custom-made fenestrated and/or branched endovascular graft in conjunction with ZTA either during the same procedure or in a staged procedure
  • A patient whose follow-up data collection is not possible (e.g. due to living abroad)

Where is this trial?

It has sites in 4 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to gather real-world clinical data demonstrating the continued safety and performance of the a marketed stent graft (Zenith® Alpha Thoracic Endovascular Graft [ZTA]) and collect longer term follow-up to better understand clinical outcomes associated with the expected lifetime of the device.

Treatments tested

  • Endovascular aortic treatment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Post-market Clinical Follow up Study on Cook Medical Zenith® Alpha Thoracic Endovascular Grafts
Record updated
27 February 2026